Suppression of hepatic gluconeogenesis in long-term troglitazone treated diabetic KK and C57BL KsJ-db db
- 30 April 1995
- journal article
- Published by Elsevier BV in Metabolism
- Vol. 44 (4), 486-490
- https://doi.org/10.1016/0026-0495(95)90056-x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Metabolic Effects of New Oral Hypoglycemic Agent CS-045 in NIDDM SubjectsDiabetes Care, 1992
- Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in
C 57BL KsJ db db Metabolism, 1991 - Effect of New Oral Antidiabetic Agent CS-045 on Glucose Tolerance and Insulin Secretion in Patients with NIDDMDiabetes Care, 1991
- In vitro studies on the action of CS-045, a new antidiabetic agentMetabolism, 1990
- Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDMDiabetes, 1989
- HORMONAL REGULATION OF HEPATIC GLUCONEOGENESIS AND GLYCOLYSISAnnual Review of Biochemistry, 1988
- Pathogenesis of insulin resistance and hyperglycemia in non-insulin-dependent diabetes mellitusAmerican Journal Of Medicine, 1985
- [12] Phosphofructokinase from rabbit liverMethods in enzymology, 1975
- Further characterization of diabetes-like abnormalities in the T-KK mouseDiabetologia, 1974
- Abnormalities in hepatic enzyme activities during development of diabetes in db miceDiabetologia, 1970